Skip to content

AngioDynamics ANGO Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
TFX
TeleflexTFX
Stryker logo
StrykerSYK
Merit Medical Systems logo
Merit Medical SystemsMMSI
ICU Medical logo
ICU MedicalICUI
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×
Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's software and technology licenses, net?
AngioDynamics (ANGO) reported software and technology licenses, net of $10.5M in Q4 2025.
How has AngioDynamics's software and technology licenses, net changed year-over-year?
AngioDynamics's software and technology licenses, net increased by 8.4% year-over-year, from $9.68M to $10.5M.
What is the long-term trend for AngioDynamics's software and technology licenses, net?
Over 4 years (2021 to 2025), AngioDynamics's software and technology licenses, net has grown at a -5.8% compound annual growth rate (CAGR), from $13.19M to $10.4M.